Biotricity (BTCY)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	509.60 k	509.60 k	509.60 k	509.60 k	509.60 k	509.60 k
Cash burn (monthly)	(no burn)	(no burn)	409.72 k	888.99 k	29.36 k	262.10 k
Cash used (since last report)	n/a	n/a	958.07 k	2.08 mm	68.66 k	612.88 k
Cash remaining	n/a	n/a	-448.47 k	-1.57 mm	440.94 k	-103.28 k
Runway (months of cash)	n/a	n/a	-1.1	-1.8	15.0	-0.4

Beta Read what these cash burn values mean

Financial data from Biotricity earnings reports.

Institutional ownership, Q2 2024

BTCY institutional ownership history Ownership history

2.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	19	16	+18.8%
Opened positions	5	16	-68.8%
Closed positions	2	1	+100.0%
Increased positions	3	0	NEW
Reduced positions	3	0	NEW

13F shares	Current	Prev Q	Change
Total value	332.43 mm	428.68 mm	-22.5%
Total shares	480.76 k	356.66 k	+34.8%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Vanguard	102.58 k	$92.29 mm	0.0%
AE Wealth Management	97.75 k	$87.95 mm	NEW
Geode Capital Management	72.25 k	$65.01 mm	+12.8%
Advisor Resource Council	69.94 k	$63.00 k	-11.5%
Strengthening Families & Communities	48.26 k	$43.00 k	0.0%
STT State Street	22.55 k	$20.29 mm	0.0%
BLK BlackRock	13.38 k	$12.03 mm	0.0%
NTRS Northern Trust	11.94 k	$10.74 mm	-0.5%
Jane Street	11.64 k	$10.47 mm	NEW
UBS UBS	9.23 k	$8.30 mm	NEW

Largest transactions	Shares	Bought/sold	Change
AE Wealth Management	97.75 k	+97.75 k	NEW
Jane Street	11.64 k	+11.64 k	NEW
UBS UBS	9.23 k	+9.23 k	NEW
Advisor Resource Council	69.94 k	-9.13 k	-11.5%
Geode Capital Management	72.25 k	+8.17 k	+12.8%
Tower Research Capital	7.72 k	+6.20 k	+406.7%
CIBC Private Wealth	334.00	+334.00	NEW
Simplex Trading	0.00	-201.00	EXIT
Advisor	410.00	+200.00	+95.2%
NTRS Northern Trust	11.94 k	-64.00	-0.5%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Press releases

From Benzinga Pro

Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025

20 Feb 25

Company reports Q3-FY25 revenue grew by 21.7% YOY to $3.6 millionManagement continues to drive revenues and efficienciesCompany achieved positive cash flow on current operating basis, before paying interest, dividends

Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%

17 Feb 25

Company expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million – an 11% increase sequentially from the immediately preceding quarterManagement continues to drive

Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform

15 Jan 25

REDWOOD CITY, Calif. and BELFAST, Northern Ireland, Jan. 15, 2025 /PRNewswire/ -- Biotricity Inc. (OTCQB:BTCY), a provider of remote cardiac monitoring solutions, and B-Secur, a leader in biosensing technology, have

Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand

27 Dec 24